Nickel-Catalyzed Aryl Borylations: Opportunities and Challenges for Innovation

J Joshua B. McManus (Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States) G Grace P. Ahlqvist (Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States) C Colton R. Davis (Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States) L Louis de Lescure (Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States) V Vaishnavi N. Nair (Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States) A Andreas R. Rötheli (Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States) B Brenda J. Burke (Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States) J Jason S. Tedrow (Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States)

Article Details

Volume / Issue Vol. 148, Issue 1
Published January 14, 2026
Pages 1-19
ISSN 0002-7863
Publisher American Chemical Society

Journal Info

Journal of the American Chemical Society

American Chemical Society

ISSN: 0002-7863 Physical Sciences

Authors (8)

J

Joshua B. McManus

Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States

G

Grace P. Ahlqvist

Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States

C

Colton R. Davis

Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States

L

Louis de Lescure

Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States

V

Vaishnavi N. Nair

Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States

A

Andreas R. Rötheli

Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States

B

Brenda J. Burke

Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States

J

Jason S. Tedrow

Commercial Process Development, CMC Synthetics Platform, Sanofi, 350 Water St, Cambridge, Massachusetts 02141-2287, United States